Ftse Mib
33.869,03
0,39%
DAX
17.991,26
0,48%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.197,97
0,13%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ DiaMedica Therapeutics Inc (DMAC) DiaMedica Therapeutics Inc (DMAC) Notizie

DiaMedica Therapeutics Inc

DMAC
2,63
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:16:52
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202414:55BWDiaMedica Therapeutics to Report First Quarter 2024..
17/4/202422:08BWDiaMedica Therapeutics Announces First Patient Dosed in..
19/3/202421:15BWDiaMedica Therapeutics Provides a Business Update and..
29/1/202422:13BWDiaMedica Therapeutics Announces Poster Presentation at..
23/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202414:23BWDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as..
02/1/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:52EDGAR2Form 8-K - Current report
13/11/202322:28BWDiaMedica Therapeutics Provides a Business Update and..
09/11/202314:25BWDiaMedica Therapeutics to Attend the 14th Annual..
06/11/202314:23BWDiaMedica Therapeutics to Report Third Quarter 2023..
12/9/202314:13BWDiaMedica Therapeutics Announces the Appointment of Ambarish..
06/9/202314:35BWDiaMedica Therapeutics to Participate at Lake Street’s 7th..
05/9/202322:15EDGAR2Form 8-K - Current report
14/8/202322:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:25EDGAR2Form 8-K - Current report
14/8/202322:13BWDiaMedica Therapeutics Provides a Business Update and..
08/8/202314:32BWDiaMedica Therapeutics to Report Second Quarter 2023..
18/7/202314:30BWDiaMedica Therapeutics to Attend the American Academy of..
10/7/202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/7/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
30/6/202322:16EDGAR2Form S-3 - Registration statement under Securities Act of..
26/6/202314:30BWDiaMedica Therapeutics Announces Closing of $37.5 Million..
21/6/202314:39BWDiaMedica Therapeutics Announces $37.5 Million Private..
21/6/202314:15BWDiaMedica Therapeutics Announces that the FDA Has Removed..
30/5/202314:29BWDiaMedica Therapeutics Announces Appointment of Dr. Richard..
15/5/202322:28BWDiaMedica Therapeutics Provides a Business Update and..
08/5/202314:50BWDiaMedica Therapeutics to Report First Quarter 2023..
Apertura: Min: Max:
Chiusura: 2,63

La tua Cronologia

NASDAQ
DMAC
DiaMedica Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network